Position Statement on COVID-19 Infection and Diabetes

  • The Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM)
Keywords: COVID-19, position statement, diabetes

Abstract

Coronavirus disease 2019 (COVID-19) has affected millions of lives worldwide, posing unprecedented challenges to global public health. It has infected people of different backgrounds, and from all industries, including healthcare workers. In China, an estimated 3000 health care workers have been infected and at least
22 have died.1 This illness has disrupted the flow of outpatient and inpatient processes, a difficult challenge for both patients and doctors.


During this time, all physicians are mobilized to make sure that the stability of healthcare continues to be provided despite the crisis. Endocrinologists have joined the frontline forces as direct health providers and/or responders to tele-consults. However, during such a crisis, it is imperative that guidelines and/or
recommendations are shared to all medical practitioners and to patients as well to ensure timely provision of care.


The PSEDM would like to provide recommendations for the clinical care of endocrine diseases during this COVID-19 crisis

Downloads

Download data is not yet available.

Author Biography

The Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM)

Jeremyjones F. Robles, MD, FPCP, FPSEDM
President, Philippine Society of Endocrinology, Diabetes & Metabolism (PSEDM)
Consultant, Section of Endocrinology, Diabetes & Metabolism
Chong Hua Hospital, Don Mariano Cui Street,
Fuente Osmeña, Cebu City, Philippines 6000
Tel.No.: +63-32-82547221 (Chong Hua Medical Arts Building Capitol Clinic)
E-mail: doc_jer_cebu@msn.com

References

Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. 2020. https://www.ncbi.nlm.nih.gov/pubmed/32163102. https://doi.org/10.1001/jama.2020.3972.

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–51. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003.

Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020. https://www.ncbi.nlm.nih.gov/pubmed/32203977. https://doi.org/10.1001/jama.2020.4683.

Philippines Department of Health information.

Adapted from the [Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68(1):2-5. https://www.ncbi.nlm.nih.gov/pubmed/32279224. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150529. https://doi.org/10.1007/s12020-020-02294-5.]

Published
2020-04-27
How to Cite
(PSEDM), T. P. S. of E. D. and M. (2020). Position Statement on COVID-19 Infection and Diabetes. Journal of the ASEAN Federation of Endocrine Societies, 35(1), 52-54. https://doi.org/10.15605/jafes.035.01.02
Section
Position Statements